On 25 February 2019, UMMC and Novotech (Malaysia) signed a Memorandum of Understanding to increase the number of clinical researches and strengthen the relationship to continue cooperation for all phases (Phase 1 -IV) of the research.

This research is in collaboration with the Clinical Research Department (CIC) as Site Management Organization (SMO) providing high-tech facilities that are regulated internationally, have highly experienced clinical practitioners in the therapeutic field to conduct high quality clinical trials and protect the rights and welfare.